Thrombotic disorder
Venous Thromboembolism: A Public Health Concern

https://doi.org/10.1016/j.amepre.2009.12.017Get rights and content

Abstract

Venous thromboembolism (VTE), defined as deep vein thrombosis, pulmonary embolism, or both, affects an estimated 300,000–600,000 individuals in the U.S. each year, causing considerable morbidity and mortality. It is a disorder that can occur in all races and ethnicities, all age groups, and both genders. With many of the known risk factors—advanced age, immobility, surgery, obesity—increasing in society, VTE is an important and growing public health problem.

Recently, a marked increase has occurred in federal and national efforts to raise awareness and acknowledge the need for VTE prevention. Yet, many basic public health functions—surveillance, research, and awareness—are still needed. Learning and understanding more about the burden and causes of VTE, and raising awareness among the public and healthcare providers through a comprehensive public health approach, has enormous potential to prevent and reduce death and morbidity from deep vein thrombosis and pulmonary embolism throughout the U.S.

Introduction

Venous thromboembolism (VTE) is a condition in which the blood clots inappropriately, causing considerable morbidity and mortality. The term VTE encompasses a continuum that includes both deep vein thrombosis (DVT), clots in the deep veins of the body; and pulmonary embolism (PE), which occurs when a clot breaks free and enters the arteries of the lungs. All races and ethnicities are affected by VTE, as are both genders and all age groups. With many of the known risk factors—advanced age, immobility, surgery, obesity—increasing in society, it is an important and growing public health problem. Yet, until recently, this condition has received little attention from the public health community. Fortunately, in many cases, VTE is preventable; thus, the importance of research and prevention of VTE is being increasingly recognized. However, critical and essential public health pieces are still missing. The current paper provides an overview of the epidemiology of VTE; discusses some recent, key public health activities; and identifies gaps in essential functions that are needed to prevent and reduce morbidity and mortality.

Section snippets

Epidemiology

Clinically, patients with VTE can be defined as presenting with DVT, PE, or both. About two thirds of patients with VTE present for care with DVT, and the remaining one third present with PE, which is the primary cause of mortality associated with VTE, often resulting in sudden death. It is also the leading cause of preventable hospital death and a leading cause of maternal mortality in the U.S. 1, 2

Public Health Activities and Gaps

Recently, there has been a marked increase in federal and national efforts to raise awareness about VTE and acknowledge it as a growing and important public health problem (Figure 1). In 2001, the Agency for Healthcare Research and Quality (AHRQ) identified prevention of VTE through appropriate thromboprophylaxis as the number-one safety practice for hospitals. 37 In 2003, the American Public Health Association (APHA) and the Centers for Disease Control and Prevention (CDC) held a Leadership

Summary and Conclusion

Venous thromboembolism is a major public health problem that affects an estimated 300,000–600,000 individuals in the U.S. each year. With many of the known acquired risks increasing in the U.S. population, we can expect to see growing numbers of people affected by VTE. Increasing surveillance, research, and awareness of VTE must be a priority. By employing a comprehensive public health approach to learning about the burden and causes of VTE and raising awareness among the public and healthcare

References (54)

  • J.A. Heit et al.

    Venous thromboembolism (VTE) characteristics among white- and black-Americans: a cross-sectional study

    Blood

    (2008)
  • W.C. Hooper et al.

    A racial difference in the prevalence of the Arg506, Gln mutation

    Thromb Res

    (1996)
  • A. Amin et al.

    Thromboprophylaxis rates in US medical centers: success or failure?

    J Thromb Haemost

    (2007)
  • J. Eikelboom et al.

    American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?

    Chest

    (2009)
  • V. Tapson et al.

    Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism

    Chest

    (2007)
  • G. Maynard et al.

    Preventing hospital-acquired venous thromboembolism: a guide for effective quality improvement

    (August 2008)
  • J. Chang et al.

    Pregnancy-related mortality surveillance—United States, 1991–1999

    MMWR CDC Surveill Summ

    (2003)
  • M.D. Silverstein et al.

    Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

    Arch Intern Med

    (1998)
  • F. Spencer et al.

    The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism

    J Gen Intern Med

    (2006)
  • R. White et al.

    Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996

    Thromb Haemost

    (2005)
  • J. Heit

    The epidemiology of venous thromboembolism in the community: implications for prevention and management

    J Thromb Thrombolysis

    (2006)
  • R. White

    The epidemiology of venous thromboembolism

    Circulation

    (2003)
  • J.A. Heit et al.

    The epidemiology of venous thromboembolism in the community

    Thromb Haemost

    (2001)
  • P. Prandoni

    Acquired risk factors for venous thromboembolism in medical patients

    Hematology

    (2005)
  • The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism

  • J.A. Heit et al.

    Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

    Arch Intern Med

    (2000)
  • S. Kahn et al.

    Prospective evaluation of health-related quality of life in patients with deep venous thrombosis

    Arch Intern Med

    (2005)
  • Cited by (0)

    View full text